TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Office Visits/statistics & numerical data
KW - Opioid-Related Disorders/drug therapy
KW - Practice Patterns, Physicians'/statistics & numerical data
KW - Vermont
AU - S. C. Sigmon
A1 - 
BT - JAMA psychiatry
C5 - Opioids & Substance Use
CP - 4
CY - United States
DO - 10.1001/jamapsychiatry.2014.2421
IS - 4
JF - JAMA psychiatry
PP - United States
PY - 2015
SN - 2168-6238; 2168-622X
SP - 395
EP - 396
EP - 
T1 - The untapped potential of office-based buprenorphine treatment
T2 - JAMA psychiatry
TI - The untapped potential of office-based buprenorphine treatment
U1 - Opioids & Substance Use
U2 - 25671806
U3 - 10.1001/jamapsychiatry.2014.2421
VL - 72
VO - 2168-6238; 2168-622X
Y1 - 2015
ER -